Paper I
2025 March (Supplementary) (2010 Scheme) · 40 marks · 120 min

Question

HMG CoA reductase inhibitors

Q200.3 marksShort Answers

Answer

Atorvastatin, Rosuvastatin (also Simvastatin) — competitively inhibit HMG-CoA reductase, upregulating hepatic LDL receptors and lowering LDL cholesterol; first-line for dyslipidemia and cardiovascular risk reduction.

Other Years Asked


Revise MBBS
Preview